ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

ASH 2015: New targeted therapies for haematological malignancies

Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival

Study finds new use for rituximab in acute lymphoblastic leukaemia

Immunotherapy makes patients’ tumours "melt away"

ASH 2015: Monoclonal antibodies for multiple myeloma

Daratumumab for multiple myeloma

Engineered cells to target multiple myeloma

Cancer Core Europe: where did it come from and what is its future?

Highlights of the EurocanPlatform Project